What does Global Blood Therapeutics do?

What does Global Blood Therapeutics do?

Global Blood Therapeutics(GBT) is a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that provide hope to underserved patient communities.

Will Global Blood Therapeutics stock go up?

Stock Price Forecast The 19 analysts offering 12-month price forecasts for Global Blood Therapeutics Inc have a median target of 72.00, with a high estimate of 138.00 and a low estimate of 38.00. The median estimate represents a +133.09% increase from the last price of 30.89.

How many employees does Global Blood Therapeutics have?

Global Blood Therapeutics has 470 Employees.

What is GBT drug?

GBT 500 (Oxbryta 500 mg) Generic Name: voxelotor. Pill with imprint GBT 500 is Yellow, Elliptical / Oval and has been identified as Oxbryta 500 mg. It is supplied by Global Blood Therapeutics Inc.. Oxbryta is used in the treatment of anemia, sickle cell and belongs to the drug class miscellaneous uncategorized agents.

How do you get SCD?

It is inherited when a child receives two sickle cell genes—one from each parent. A person with SCD can pass the disease or SCT on to his or her children. How Does Someone Get Sickle Cell Trait? People who have inherited one sickle cell gene and one normal gene have SCT.

What is vaso occlusive crisis?

Pain crisis (also called vaso-occlusive crisis) This occurs when the flow of blood is blocked to an area because the sickle-shaped cells have become stuck in the blood vessel.

Is GBT a good stock to buy?

The financial health and growth prospects of GBT, demonstrate its potential to underperform the market. It currently has a Growth Score of D. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D.

Is Global Blood Therapeutics a good investment?

Global Blood Therapeutics has received a consensus rating of Buy.

Can SCD be cured?

Yes! A blood or marrow transplant (BMT) is the only known cure for SCD. BMT is not surgery. It's a treatment that takes healthy blood-forming cells from a donor and gives them to you through an intravenous (IV) infusion to replace the unhealthy cells.

How do you know if a baby is a Sickler?

If your baby has Hb SS, they will have a large number of red blood cells that are sickle or crescent shaped rather than donut-shaped. Clinical genetic testing for Hb SS is available and may be necessary to confirm the diagnosis.

What does Global Blood Therapeutics do for a living?

• Global Blood Therapeutics Inc. Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases.

Is Global Blood Therapeutics (GBT) a buy at Wedbush?

• Global Blood Therapeutics (GBT) Gets a Buy Rating from Wedbush. Wedbush analyst Liana Moussatos reiterated a Buy rating on Global Blood Therapeutics (GBT) today and set a price target of $103.

Is Global Blood Therapeutics' sickle cell treatment approved by the FDA?

• Global Blood Therapeutics Inc said on Tuesday the U.S. Food and Drug Administration had granted priority review for two applications related to its treatment for sickle cell disease in children.